Nutex Health (NASDAQ:NUTX) Stock Price Down 5% – Should You Sell?

Nutex Health Inc. (NASDAQ:NUTXGet Free Report)’s share price dropped 5% on Wednesday . The stock traded as low as $17.66 and last traded at $18.57. Approximately 88,118 shares changed hands during trading, an increase of 122% from the average daily volume of 39,663 shares. The stock had previously closed at $19.54.

Wall Street Analysts Forecast Growth

Several equities research analysts have weighed in on NUTX shares. Benchmark increased their target price on shares of Nutex Health from $30.00 to $45.00 and gave the stock a “buy” rating in a report on Wednesday, August 21st. Maxim Group initiated coverage on Nutex Health in a research note on Wednesday, September 18th. They set a “buy” rating and a $45.00 price objective on the stock.

View Our Latest Analysis on NUTX

Nutex Health Price Performance

The company has a market cap of $92.33 million, a P/E ratio of -1.75 and a beta of 0.10. The company’s 50-day moving average price is $18.93 and its 200-day moving average price is $11.43. The company has a debt-to-equity ratio of 3.04, a current ratio of 1.59 and a quick ratio of 1.55.

Nutex Health (NASDAQ:NUTXGet Free Report) last released its earnings results on Thursday, August 8th. The company reported ($0.07) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.29) by $0.22. The firm had revenue of $76.08 million during the quarter. Nutex Health had a negative return on equity of 43.79% and a negative net margin of 13.73%.

Insider Activity at Nutex Health

In other news, CFO Jon Christian Bates purchased 1,350 shares of Nutex Health stock in a transaction on Thursday, August 22nd. The stock was purchased at an average price of $21.46 per share, with a total value of $28,971.00. Following the transaction, the chief financial officer now directly owns 2,277 shares in the company, valued at $48,864.42. The trade was a 100.00 % increase in their position. The acquisition was disclosed in a document filed with the SEC, which can be accessed through this link. 38.52% of the stock is owned by insiders.

Institutional Investors Weigh In On Nutex Health

An institutional investor recently raised its position in Nutex Health stock. One Plus One Wealth Management LLC lifted its stake in Nutex Health Inc. (NASDAQ:NUTXFree Report) by 2,017.5% during the first quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 5,293,720 shares of the company’s stock after acquiring an additional 5,043,720 shares during the quarter. One Plus One Wealth Management LLC owned approximately 0.71% of Nutex Health worth $508,000 as of its most recent SEC filing. Hedge funds and other institutional investors own 5.32% of the company’s stock.

About Nutex Health

(Get Free Report)

Nutex Health Inc operates as a physician-led, healthcare services, and operations company. It operates through three segments: Hospital, Population Health Management (PHM), and Real Estate. The PHM segment establishes and operates independent physician associations; and offers a cloud-based platform for healthcare organizations to provide value-based care and population health management.

See Also

Receive News & Ratings for Nutex Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nutex Health and related companies with MarketBeat.com's FREE daily email newsletter.